Biomolecules (Jan 2024)

Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate

  • Hafsia Abbas,
  • Dalia Kheira Derkaoui,
  • Louise Jeammet,
  • Emilie Adicéam,
  • Jérôme Tiollier,
  • Hélène Sicard,
  • Thorsten Braun,
  • Jean-Luc Poyet

DOI
https://doi.org/10.3390/biom14010136
Journal volume & issue
Vol. 14, no. 1
p. 136

Abstract

Read online

Apoptosis, or programmed cell death, is a fundamental process that maintains tissue homeostasis, eliminates damaged or infected cells, and plays a crucial role in various biological phenomena. The deregulation of apoptosis is involved in many human diseases, including cancer. One of the emerging players in the intricate regulatory network of apoptosis is apoptosis inhibitor 5 (API5), also called AAC-11 (anti-apoptosis clone 11) or FIF (fibroblast growth factor-2 interacting factor). While it may not have yet the same level of notoriety as some other cancer-associated proteins, API5 has garnered increasing attention in the cancer field in recent years, as elevated API5 levels are often associated with aggressive tumor behavior, resistance to therapy, and poor patient prognosis. This review aims to shed light on the multifaceted functions and regulatory mechanisms of API5 in cell fate decisions as well as its interest as therapeutic target in cancer.

Keywords